Jazz Pharmaceuticals (JAZZ +2.8%) posts another gain after Friday's big post-Q2 earnings report...

|About: Jazz Pharmaceuticals, Inc. (JAZZ)|By:, SA News Editor

Jazz Pharmaceuticals (JAZZ +2.8%) posts another gain after Friday's big post-Q2 earnings report jump. Jefferies upgrades shares to a Buy from Hold with a $52 price target noting the firm "previously modeled only 5% volume growth in '11-'13," but now sees "double-digit growth."